default author photo

Wenxi Tang

China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research

Nanjing

China

  • China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research

SCHOLARLY PAPERS

8

DOWNLOADS

624

TOTAL CITATIONS

1

Scholarly Papers (8)

Actions:
Email selected abstracts
1.

When Is It Valuable for COVID-19 Booster Dose?: A Transmission Dynamics Model-Based Effectiveness and Cost-Effectiveness Analysis of Two Booster Dose Vaccination Priority Strategies in Mainland China

Number of pages: 23 Posted: 26 Nov 2021
Dachuang Zhou, Taihang Shao, Hanqiao Shao, Yusi Tu, Yaqian Tang, Jifang Zhou, Daniel C. Malone and Wenxi Tang
China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University, University of Utah and China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research
Downloads 143 (518,102)

Abstract:

Loading...

2.

Air Pollution-Related Economic Burden in China, 1990-2050: A Modelling Study Based on Global Burden of Disease

Downloads 113 (635,507)
Citation 1

Air Pollution-Related Economic Burden in China, 1990-2050: A Modelling Study Based on Global Burden of Disease

Number of pages: 114 Posted: 03 Sep 2024
Dachuang Zhou, Yang Yang, Zhenping Zhao, Kejia Zhou, Di Zhang, Wenxi Tang and Maigeng Zhou
China Pharmaceutical University, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research and Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention
Downloads 80 (819,435)

Abstract:

Loading...

Air pollution, economic impact, China, modelling study

Air Pollution-Related Economic Burden in China, 1990-2050: A Modelling Study Based on Global Burden of Disease

Number of pages: 25 Posted: 10 Oct 2024
Dachuang Zhou, Yang Yang, Zhenping Zhao, Kejia Zhou, Di Zhang, Wenxi Tang and Maigeng Zhou
China Pharmaceutical University, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research and Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention
Downloads 33 (1,326,242)
Citation 1

Abstract:

Loading...

Air pollution, Cost of illness, Health impact, Economic burden

3.

Health-Augmented Macroeconomic Model Estimated Economic Disease Burden of 29 Cancers in China: 1992–2021

Number of pages: 23 Posted: 09 Jul 2024
Qian Mao, Qian Peng, Liying Geng, Zhenping Zhao, Maigeng Zhou and Wenxi Tang
Department of Health Statistics, School of Public Health, Weifang Medical University, China Pharmaceutical University, China Pharmaceutical University, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention and China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research
Downloads 94 (725,554)

Abstract:

Loading...

cancer, health-related macroeconomic model, economic burden, disease bursen, China

4.

Impacts of Systemic Treatments On Health-Related Quality of Life for Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis

Number of pages: 24 Posted: 23 Aug 2023
Yunlin Jiang, Mingye Zhao, Yue Yin, Xue ping Zheng and Wenxi Tang
Nanjing University of Chinese Medicine (NJUCM), China Pharmaceutical University, China Pharmaceutical University, Nanjing University of Chinese Medicine (NJUCM) and China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research
Downloads 75 (844,901)

Abstract:

Loading...

Metastatic colorectal cancer, Health-related quality of life, Network meta-analysis, Systematic review, Treatment selection

5.

Cost-Effectiveness of a Digital Adherence Technology-Based Intervention for Tuberculosis Management in Tibet, China: A Pragmatic Randomised Controlled Trial

Number of pages: 23 Posted: 28 Oct 2025
Chenxi Liu, Zhitong Zhang, Feng Xie, Wenxi Tang, Jun Hu, Pande Pasang and Xiaolin Wei
Huazhong University of Science and Technology, University of Toronto - Dalla Lana School of Public Health, McMaster University - Department of Health Research Methods, Evidence, and Impact (HEI), China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research, Shigatse Centre for Disease Control and Prevention, Shigatse Centre for Disease Control and Prevention and University of Toronto - Dalla Lana School of Public Health
Downloads 59 (989,921)

Abstract:

Loading...

Digital adherence technologies, cost-effectiveness, tuberculosis, pragmatic randomised controlled trial

6.

Economic Burden Attributable to High BMI in China, 1990–2023: A Modelling Study Based on Global Burden of Disease 2023

Number of pages: 34 Posted: 18 Dec 2025
Ruiyi Zhang, Yue Yin, Mingye Zhao, Wenxi Tang and See PDF
Shandong University, China Pharmaceutical University, China Pharmaceutical University, China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research and Please see PDF for full list of authors & affiliations
Downloads 56 (1,020,567)

Abstract:

Loading...

High body-mass index, Value of a statistical life, Economic burden, China

7.

Economic Disease Burden of 27 Cancers in China from 1992–2050: A Health–Augmented Macroeconomic Modelled Study Using Global Burden of Disease 2023

Number of pages: 32 Posted: 19 Feb 2026
Qian Mao, Qian Peng, Liying Geng, Zhenping Zhao, Maigeng Zhou and Wenxi Tang
Department of Health Statistics, School of Public Health, Weifang Medical University, China Pharmaceutical University, China Pharmaceutical University, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC) - National Center for Chronic and Noncommunicable Disease Control and Prevention and China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research
Downloads 42 (1,263,436)

Abstract:

Loading...

Cancers, China, Economic Burden, Disease Burden, Health-Augmented Macroeconomic Model, Global Burden of Diseases

8.

The Productivity Adjusted Life Years (PALY) of Refractory and Non-Refractory Generalized Myasthenia Gravis Patients and Caregivers in China: A National Estimate from a 300-Participants Survey

Number of pages: 30 Posted: 28 Jan 2026
Liying Geng, Yuhong Liu and Wenxi Tang
China Pharmaceutical University, China Pharmaceutical University and China Pharmaceutical University - Center for Pharmacoeconomics and Outcomes Research
Downloads 42 (1,277,121)

Abstract:

Loading...

Productivity adjusted life years, Productivity burden, Generalized myasthenia gravis, Refractory generalized myasthenia gravis, Caregivers, China